Better Therapeutics, Inc.

The conference will begin shortly. To raise your hand during Q&A, you can dial star 1 1.

Good morning and welcome to the Better Therapeutics Second Quarter 2022 Financial Results and Business Update conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you'll need to press star 1-1 on your telephone. I would now like to turn the call over to Mark Heinen, Chief Financial Officer. Please go ahead.

Thank you, Operator. Good morning, everyone, and welcome to the Better Therapeutics conference call to discuss our second quarter 2022 financial results and business update. Our press release was issued this morning and can be found in the investor section of our corporate website, bettertx.com. Joining me on the call this morning is Frank Carva, our President and Chief Executive Officer, Dr. Mark Berman, our Chief Medical Officer, and Dr. D.P. Jaggi, our Chief Strategy and Commercial Officer. During today's call, the team will provide a business and financial overview of the second quarter of 2022 and provide our outlook for the third quarter of 2022 and beyond. A Q&A session will follow our prepared remarks. Before we begin, and as a reminder, today's discussion will include forward-looking statements related to Better Therapeutics' current plans and expectations, which are subject to certain risks and uncertainties. Actual results may differ materially due to various important factors, including those described in the risk factor section of our most recent SEC filing. These forward-looking statements represent our views as of this call and should not be relied upon as representing our views as of any subsequent date. We undertake no obligation to publicly update these statements. With that, I'll pass the call over to Frank Harbaugh. Frank?